What is it about?
Following two studies done in 2007 and 2009, a follow-up of the adherence to the suggested guidelines on drug standardisation has been performed with a suggestion for future standards that can be achieved, to complement the recently published Carter report. The Intensive Care Society (ICS) introduced recommendations for infusion concentrations of 16 medications commonly used in critical care areas. The importance being improvement in patient safety and rationalised use of available critical care resources. Five years after publication of these recommendations, a further audit has been undertaken to assess the level of acceptance and application. This revealed that 89.5% of the 133 surveyed units (representing 42.49% critical care units across the UK) have adopted the recommendations. There are further medication concentrations which could also be standardised.
Featured Image
Why is it important?
Drug standardisation of concentration and preparation improves Safety , Training , Cost saving , and increases Efficiency in time saving .
Perspectives
Intravenous drug standardisation will allow trainees to be familiar with preparations between different trusts without having to familiarise themselves with new concentrations. Intravenous drugs can be prepared prepackaged ready to infuse avoiding error in reconstitution which is considerable . This will reduce patient morbidity and mortality. Medications will be cheaper for the trusts as they will be mass produced.
Dr Peter A Keeling
frimley park hospital
Read the Original
This page is a summary of: Infusion medication concentrations in UK’s critical care areas: Are the Intensive Care Society’s recommendations being used?, Journal of the Intensive Care Society, July 2016, SAGE Publications,
DOI: 10.1177/1751143716662664.
You can read the full text:
Contributors
The following have contributed to this page
